Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis ; volume:12 ; number:3 ; year:2019 ; pages:834-837
Case reports in oncology ; 12, Heft 3 (2019), 834-837
- Creator
-
Tsutsui, Miyuki
Yasuda, Hajime
Ota, Yasunori
Komatsu, Norio
- DOI
-
10.1159/000504129
- URN
-
urn:nbn:de:101:1-2020011600121602515932
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsutsui, Miyuki
- Yasuda, Hajime
- Ota, Yasunori
- Komatsu, Norio
Other Objects (12)
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
Biological drivers of clinical phenotype in myelofibrosis
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
Biological drivers of clinical phenotype in myelofibrosis
Myelofibrosis
Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
Novel approaches in myelofibrosis
Myelofibrosis Treatment Algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018
Management of myelofibrosis after ruxolitinib failure
Concerns regarding myelofibrosis-type megakaryocyte dysplasia
Myelofibrosis treatment history and future prospects
Prognostic and Predictive Models in Myelofibrosis
Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction
JAK Inhibitors for Myelofibrosis: Strengths and Limitations